Cancer Treatment News and Research

RSS

Exercise relieves cancer fatigue

A review of studies spanning 45 years shows that exercise, particularly aerobic rather than strength- or flexibility-based training, improves fatigue in cancer patients.

21 Nov 2012

New solar steam method from Rice University

Rice University scientists have unveiled a revolutionary new technology that uses nanoparticles to convert solar energy directly into steam. The new "solar steam" method from Rice's Laboratory for Nanophotonics (LANP) is so effective it can even produce steam from icy cold water.

20 Nov 2012

Loyola explores different prostate cancer websites for meaningful medical information

Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?

17 Nov 2012

Study shows boost in access to screening for breast and cervical cancer

A study by researchers at the George Washington University School of Public Health and Health Services indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more low-income women, enabling more than a million women to obtain potentially life-saving screening for breast and cervical cancer.

16 Nov 2012

Study on effect of glucose on cancer growth in mice

An animal study conducted by researchers at Georgetown Lombardi Comprehensive Cancer Center raises questions about the consequences of diet - specifically glucose, the plant-based sugar that fuels cell life - on increased activity of an oncogene that drives tumor growth.

15 Nov 2012

Cancer-related fatigue can be helped by aerobic exercise

Aerobic exercise can help relieve the fatigue often associated with cancer and cancer treatment, according to Cochrane researchers. Their updated systematic review strengthens findings from an earlier version on cancer-related fatigue published in The Cochrane Library.

14 Nov 2012

Lung cancer stem cells can be isolated and grown in preclinical models

A University of Cincinnati (UC) Cancer Institute lung cancer research team reports that lung cancer stem cells can be isolated-and then grown-in a preclinical model, offering a new avenue for investigating immunotherapy treatment options that specifically target stem cells.

14 Nov 2012

Tiltan Pharma initiates enrollment in TL-118 Phase 2 trial for metastatic pancreatic cancer

Tiltan Pharma Ltd. today announced that it has enrolled the first U.S. patient, at White Plains Hospital in Westchester County N.Y., in a Phase 2 clinical trial of its anti-angiogenic product, TL-118, for the treatment of metastatic pancreatic cancer.

14 Nov 2012

Reflexology can help cancer patients manage their symptoms and perform daily tasks

A study led by a Michigan State University researcher offers the strongest evidence yet that reflexology - a type of specialized foot massage practiced since the age of pharaohs - can help cancer patients manage their symptoms and perform daily tasks.

14 Nov 2012

SCCA to raise awareness about importance of lung cancer screening

Lung cancer is the No. 1 cause of cancer deaths in the United States, despite the fact it is largely preventable. For people at high risk of developing lung cancer, such as current or former longtime smokers, screening for the disease with low-dose CT scans is now a viable option that has been shown to significantly reduce mortality rates. In conjunction with National Lung Cancer Awareness Month, Seattle Cancer Care Alliance (SCCA) wants to raise awareness about the importance of prevention and early detection for at-risk populations.

9 Nov 2012

Scientists show how sorafenib can be dangerous to the heart

Scientists for the first time have evidence showing how a widely used type of "targeted" cancer drug can be dangerous to the heart.

7 Nov 2012

Drug trio may reduce eliminate cardiac side effects of doxorubicin

Combining cancer medication with a drug for erectile dysfunction and one for heart transplants helped kill cancer cells and protected the heart from damage, in a study presented at the American Heart Association's Scientific Sessions 2012.

7 Nov 2012

Bristol-Myers Squibb welcomes decision by NICE to recommend Yervoy for advanced melanoma

Today, Bristol-Myers Squibb is pleased to welcome the decision by The National Institute for Health and Clinical Excellence (NICE) to recommend Yervoy (ipilimumab) for the treatment of previously-treated advanced (unresectable or metastatic) melanoma within the Final Appraisal Determination (FAD).

3 Nov 2012

New tool can particularly sort tumor-causing cancer cells

A new tool developed by scientists at The Methodist Hospital separates tumor-causing cancer cells from more benign cells by subjecting the cells to a microscopic game of Plinko -- except only the squishiest cells make it through.

3 Nov 2012

New partnership to make advancements in personalized breast cancer treatment and care

The Edith Sanford Breast Cancer Foundation and The Scripps Research Institute today announced the formation of a dynamic partnership that will lay the groundwork for lifesaving advancements in personalized breast cancer treatment and care.

3 Nov 2012

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

Bristol-Myers Squibb Company is pleased to announce that today the National Institute of Health and Clinical Excellence (NICE) has decided to recommend YERVOY (ipilimumab), which is approved in the European Union for the treatment of previously-treated metastatic (advanced) melanoma, within the Final Appraisal Determination (FAD).

3 Nov 2012

HPV test of cure cheaper and more effective than cytology testing for women following pre-cervical cancer treatment

Testing women to see if they are cured of HPV (the virus that can cause genital warts and cervical cancer) following treatment for abnormal cells on the surface of the cervix is more effective and cheaper than cytology testing (cervical screening) alone, suggests a study published on bmj.com.

2 Nov 2012

Link between ChemoFx Drug Response Marker results and RFS of cervical cancer patients

A new study reporting an association between ChemoFx Drug Response Marker results and recurrence free survival (RFS) of cervical cancer patients was presented at the 14th Biennial Meeting of the International Gynecologic Cancer Society (IGCS), held in Vancouver October 13-16, 2012.

2 Nov 2012

Varian highlights numerous lung cancer treatment systems at ASTRO meeting

Varian Medical Systems highlighted the company's technologies for the non-invasive treatment of lung cancer at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston this week.

1 Nov 2012

Proton therapy preserves urinary and bowel function in men with prostate cancer

Two studies led by The University of Texas MD Anderson Cancer Center have found that proton therapy preserves the quality of life, specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer.

30 Oct 2012

Cancer Treatment News and Research

Exercise relieves cancer fatigue

New solar steam method from Rice University

Loyola explores different prostate cancer websites for meaningful medical information

Study shows boost in access to screening for breast and cervical cancer

Study on effect of glucose on cancer growth in mice

Cancer-related fatigue can be helped by aerobic exercise

Lung cancer stem cells can be isolated and grown in preclinical models

Tiltan Pharma initiates enrollment in TL-118 Phase 2 trial for metastatic pancreatic cancer

Reflexology can help cancer patients manage their symptoms and perform daily tasks

SCCA to raise awareness about importance of lung cancer screening

Scientists show how sorafenib can be dangerous to the heart

Drug trio may reduce eliminate cardiac side effects of doxorubicin

Bristol-Myers Squibb welcomes decision by NICE to recommend Yervoy for advanced melanoma

New tool can particularly sort tumor-causing cancer cells

New partnership to make advancements in personalized breast cancer treatment and care

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

HPV test of cure cheaper and more effective than cytology testing for women following pre-cervical cancer treatment

Link between ChemoFx Drug Response Marker results and RFS of cervical cancer patients

Varian highlights numerous lung cancer treatment systems at ASTRO meeting

Proton therapy preserves urinary and bowel function in men with prostate cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News